Trial Profile
A retropsetive comparison trial of garenoxacin with levofloxacin as antimicrobial prophylaxis in acute myeloid leukemia
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 04 Nov 2015
Price :
$35
*
At a glance
- Drugs Garenoxacin (Primary) ; Levofloxacin (Primary)
- Indications Bacterial infections; Gram-positive infections; Myeloid leukaemia
- Focus Therapeutic Use
- 04 Nov 2015 New trial record